Company Overview

Humana Inc. is a prominent American health insurance company headquartered in Louisville, Kentucky. In 2024, it held the 92nd position on the Fortune 500 list, making it the highest-ranked company by revenue based in Kentucky. It stands as the fourth-largest health insurance provider in the United States. Humana Inc. (NYSE: HUM) is a leading U.S. health insurer that specializes in Medicare Advantage plans, government-sponsored programs, and integrated healthcare services, operating through its insurance and CenterWell health services segments.

Business Segments and Operations

The company operates through two primary segments: Insurance and CenterWell. Humana has transitioned from being solely a traditional insurer to an integrated healthcare provider, emphasizing value-based care models and comprehensive health services.

Insurance Segment

This segment offers medical care and supplemental benefit plans to individuals. Humana also holds a contract with the Centers for Medicare and Medicaid Services (CMS) to administer the Limited Income Newly Eligible Transition (LI NET) prescription drug plan program. Additionally, it contracts with various states to provide Medicaid, dual-eligible, and long-term support services benefits.

The company also provides commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health benefits, as well as administrative services only (ASO) products for individuals and employer groups. It also offers military services, such as the TRICARE T2017 East Region contract.

CenterWell Health Services

CenterWell encompasses primary care, home health, and pharmacy services. It currently operates 249 centers, representing a 16% growth. The Primary Care Organization (PCO) manages a total of 214 senior-focused primary care clinics, including 37 under a joint venture with WCAS and 177 wholly owned centers. These 214 clinics, operating under the CenterWell Senior Primary Care and Conviva Care Solutions brands, serve approximately 180,000 patients in Medicare value-based arrangements. They also support 58,000 patients through Independent Practice Association (IPA) arrangements via Conviva Care Solutions.

Financial Performance

Fourth Quarter and Full Year 2024 Results

Humana reported a net loss per share of $5.76 on a GAAP basis for Q4 2024, and an adjusted net loss per share of $2.16. For the full fiscal year 2024, the company reported earnings per share (EPS) of $9.98 on a GAAP basis and $16.21 on an Adjusted basis, as reported in February 2025.

In 2024, Humana generated a profit of $1.2 billion, a decrease of more than half from $2.5 billion in 2023. This decline was attributed to significantly higher spending on member care within its Medicare and Medicaid programs, according to financial results released in February 2025. Humana's shares saw a decline of 42% in value from the beginning of 2024.

First Quarter 2025 Performance

For the first quarter of 2025, Humana reported earnings per share (EPS) of $10.30 on a GAAP basis, and an Adjusted EPS of $11.58. The Insurance segment's benefit ratio for Q1 2025 was 87.4 percent, aligning with the company's previously disclosed expectation of "approximately 87.5 percent," as reported in April 2025.

Financial Guidance and Outlook

Humana has affirmed its previous guidance for Adjusted FY 2025 EPS, expecting it to be "at least in line with 2024 results." The company anticipates GAAP EPS of approximately $15.88, or approximately $16.25 on an Adjusted basis, which includes incremental investments aimed at supporting operational excellence.

For 2025, Humana Inc. (NYSE:HUM) has raised its revenue guidance to at least $128 billion. This upward revision is driven by stronger-than-expected medical cost control and growth within its pharmacy business.

Membership and Market Position

Medicare Advantage Challenges

Humana expects an individual Medicare Advantage annual membership decline of approximately 550,000, or about 10 percent, from 2024 levels. This estimate includes the company's strategic decision to exit certain unprofitable plans and counties. However, the company later revised its individual Medicare Advantage membership outlook, now projecting a decline of up to 500,000 members, an improvement from the previous estimate of 550,000.

As of January 2025, Humana's individual Medicare Advantage book had decreased by 8%, representing a loss of almost 445,000 members compared to the end of 2024.

Star Ratings Impact

The number of Humana's Medicare Advantage plans rated 4-star or higher is expected to significantly decline in 2025. Humana has filed a lawsuit seeking to overturn and vacate the 2025 Star Ratings of its Medicare Advantage plans. However, there is no guarantee that the company will prevail in this litigation. Should the company be unsuccessful, the decline in Star Ratings will negatively impact its 2026 quality bonus payments from CMS and could also adversely affect the company's revenues, operating results, and cash flows.

Strategic Initiatives and Growth Areas

CenterWell Expansion

CenterWell Primary Care has demonstrated strong performance, with anticipated FY 2025 net patient growth projected between 50,000 to 70,000, surpassing previous expectations.

A new joint venture aims to deploy up to $1.2 billion in committed capital to develop approximately 100 new senior-focused, payer-agnostic primary care clinics between 2023 and 2025, and operate them to profitability.

Value-Based Care Focus

Humana (NYSE: HUM) has released new research highlighting the effectiveness of value-based care for Medicare Advantage patients diagnosed with heart failure. The study indicated that patients treated by value-based care clinicians were 28% more likely to receive full quadruple therapy, which is considered the gold standard treatment for heart failure.

Prior Authorization Reforms

Humana (NYSE:HUM) has announced significant reforms to streamline its prior authorization requirements. The objective is to reduce administrative burdens and enhance patient care access. By January 1, 2026, the company plans to eliminate approximately one-third of prior authorizations for outpatient services and commit to providing decisions within one business day for 95% of complete electronic prior authorization requests.

Medicaid and Government Programs

In the first quarter, Medicaid contracts in Louisiana and Ohio added 215,000 members as of March 31. This number is anticipated to grow to over 1.3 million members across seven states. Humana continues to advance its Medicaid and CenterWell strategies, which are expected to drive increased earnings contributions over the mid and longer term.

Humana maintains its strategic focus on government-sponsored healthcare programs, holding strong positions in Medicare Advantage while strategically expanding its Medicaid footprint and integrated healthcare services via the CenterWell platform. The company's ongoing transformation into a comprehensive healthcare services provider positions it to capitalize on the increasing demand for value-based care solutions within the evolving healthcare landscape.